{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:02:52Z","timestamp":1764079372346,"version":"3.45.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,25]]},"DOI":"10.7759\/cureus.97745","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:49:41Z","timestamp":1764078581000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Prostate Imaging Reporting and Data System (PI-RADS) Score and Prostate-Specific Antigen Density (PSAD) With Prostate Biopsy Histology Outcomes: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Vignesh","family":"Balasubaramaniam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Kailasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurul Aimi B","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arran","family":"Shoker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine V","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krassen","family":"Donev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanmugasigamani","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global Cancer Statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global Cancer Statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","unstructured":"Data & Evidence Library for Health Improvement (DELHI). (2021). Accessed. 31 July 2025: https:\/\/prostatecanceruk.org\/for-health-professionals\/data-and-evidence."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29538","article-title":"Prevalence of incidental prostate cancer: a systematic review of autopsy studies","volume":"137","author":"Bell KJ","year":"2015","unstructured":"Bell KJ, Del Mar C, Wright G, Dickinson J, Glasziou P. Prevalence of incidental prostate cancer: a systematic review of autopsy studies. Int J Cancer. 2015, 137:1749-57. 10.1002\/ijc.29538","journal-title":"Int J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.12.052","article-title":"Multiparametric magnetic resonance imaging (MRI) and MRI-transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen","volume":"70","author":"Radtke JP","year":"2016","unstructured":"Radtke JP, Schwab C, Wolf MB, et al.. Multiparametric magnetic resonance imaging (MRI) and MRI-transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen. Eur Urol. 2016, 70:846-53. 10.1016\/j.eururo.2015.12.052","journal-title":"Eur Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update","volume":"76","author":"Babjuk M","year":"2019","unstructured":"Babjuk M, Burger M, Comp\u00e9rat EM, et al.. European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update. Eur Urol. 2019, 76:639-57. 10.1016\/j.eururo.2019.08.016","journal-title":"Eur Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.12.010","article-title":"Magnetic resonance imaging-defined prostate-specific antigen density significantly improves the risk prediction for clinically significant prostate cancer on biopsy","volume":"126","author":"Bhat NR","year":"2019","unstructured":"Bhat NR, Vetter JM, Andriole GL, Shetty AS, Ippolito JE, Kim EH. Magnetic resonance imaging-defined prostate-specific antigen density significantly improves the risk prediction for clinically significant prostate cancer on biopsy. Urology. 2019, 126:152-7. 10.1016\/j.urology.2018.12.010","journal-title":"Urology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13465","article-title":"Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy na\u00efve patients","volume":"119","author":"Washino S","year":"2017","unstructured":"Washino S, Okochi T, Saito K, Konishi T, Hirai M, Kobayashi Y, Miyagawa T. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy na\u00efve patients. BJU Int. 2017, 119:225-33. 10.1111\/bju.13465","journal-title":"BJU Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.03.130","article-title":"The value of PSA density in combination with PI-RADS\u2122 for the accuracy of prostate cancer prediction","volume":"198","author":"Distler FA","year":"2017","unstructured":"Distler FA, Radtke JP, Bonekamp D, et al.. The value of PSA density in combination with PI-RADS\u2122 for the accuracy of prostate cancer prediction. J Urol. 2017, 198:575-82. 10.1016\/j.juro.2017.03.130","journal-title":"J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.08.002","article-title":"Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic review and meta-analysis","volume":"7","author":"Wang S","year":"2024","unstructured":"Wang S, Kozarek J, Russell R, et al.. Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic review and meta-analysis. Eur Urol Oncol. 2024, 7:189-203. 10.1016\/j.euo.2023.08.002","journal-title":"Eur Urol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and data system: 2015, version 2","volume":"69","author":"Weinreb JC","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, et al.. PI-RADS prostate imaging - reporting and data system: 2015, version 2. Eur Urol. 2016, 69:16-40. 10.1016\/j.eururo.2015.08.052","journal-title":"Eur Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12533","article-title":"International Society of Urological Pathology (ISUP) grading of prostate cancer - an ISUP consensus on contemporary grading","volume":"124","author":"Egevad L","year":"2016","unstructured":"Egevad L, Delahunt B, Srigley JR, Samaratunga H. International Society of Urological Pathology (ISUP) grading of prostate cancer - an ISUP consensus on contemporary grading. APMIS. 2016, 124:433-5. 10.1111\/apm.12533","journal-title":"APMIS"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15277","article-title":"Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation","volume":"127","author":"Schoots IG","year":"2021","unstructured":"Schoots IG, Padhani AR. Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int. 2021, 127:175-8. 10.1111\/bju.15277","journal-title":"BJU Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.05.024","article-title":"Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer","volume":"38","author":"Stevens E","year":"2020","unstructured":"Stevens E, Truong M, Bullen JA, Ward RD, Purysko AS, Klein EA. Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer. Urol Oncol. 2020, 38:846.e9-16. 10.1016\/j.urolonc.2020.05.024","journal-title":"Urol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2018.09.001","article-title":"Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7-10 prostate cancer in biopsy-naive men","volume":"2","author":"Boesen L","year":"2019","unstructured":"Boesen L, N\u00f8rgaard N, L\u00f8gager V, et al.. Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7-10 prostate cancer in biopsy-naive men. Eur Urol Oncol. 2019, 2:311-9. 10.1016\/j.euo.2018.09.001","journal-title":"Eur Urol Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76786-9","article-title":"The use of prostate specific antigen density to predict clinically significant prostate cancer","volume":"10","author":"Yusim I","year":"2020","unstructured":"Yusim I, Krenawi M, Mazor E, Novack V, Mabjeesh NJ. The use of prostate specific antigen density to predict clinically significant prostate cancer. Sci Rep. 2020, 10:20015. 10.1038\/s41598-020-76786-9","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2022.10.002","article-title":"Prostate-specific antigen density cutoff of 0.15 ng\/mL\/cc to propose prostate biopsies to patients with negative magnetic resonance imaging: efficient threshold or legacy of the past?","volume":"9","author":"Pellegrino F","year":"2023","unstructured":"Pellegrino F, Tin AL, Martini A, et al.. Prostate-specific antigen density cutoff of 0.15 ng\/mL\/cc to propose prostate biopsies to patients with negative magnetic resonance imaging: efficient threshold or legacy of the past?. Eur Urol Focus. 2023, 9:291-7. 10.1016\/j.euf.2022.10.002","journal-title":"Eur Urol Focus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)40079-6","article-title":"Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia","volume":"143","author":"Partin AW","year":"1990","unstructured":"Partin AW, Carter HB, Chan DW, et al.. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol. 1990, 143:747-52. 10.1016\/s0022-5347(17)40079-6","journal-title":"J Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10681.x","article-title":"The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume","volume":"110","author":"Corcoran NM","year":"2012","unstructured":"Corcoran NM, Casey RG, Hong MK, et al.. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume. BJU Int. 2012, 110:36-42. 10.1111\/j.1464-410X.2011.10681.x","journal-title":"BJU Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/430695-association-of-prostate-imaging-reporting-and-data-system-pi-rads-score-and-prostate-specific-antigen-density-psad-with-prostate-biopsy-histology-outcomes-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:49:42Z","timestamp":1764078582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/430695-association-of-prostate-imaging-reporting-and-data-system-pi-rads-score-and-prostate-specific-antigen-density-psad-with-prostate-biopsy-histology-outcomes-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.97745","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}